Behavioral Health Innovations Lab Accomplishments

Team News

• Aug. 2024: Dr. Dahne, along with Dr. Evan Graboyes, received a $3.1 million grant from the National Cancer Institute for a clinical trial to test their new model of depression treatment for patients living with advanced and metastatic cancer.
• Feb. 2024: Ebonie White, who was mentored by Dr. Dahne through the DART program, accepted a Ph.D. program offer at the University of Memphis for clinical psychology.
• Dec. 2023: Olivia Levins was awarded the 2023 Scientific Poster Winner title at the 2023 Telehealth Conference for her poster "Vape X: A Digital Vaping Cessation Intervention for Adolescents with Depression."
• Nov. 13, 2023: Dr. Dahne was selected for the MUSC President’s Values in Action Awards. Way to go, Dr. Dahne!
• Oct. 9, 2023: Juliana Hayden joined Behavioral Health Innovations Lab as our newest program assistant. Welcome Juliana!
• June 12, 2023: Behavioral Health Innovations Lab welcomed one new program assistant to the team. Welcome Katherine Bullard!
• June 1, 2023: Dr. Dahne discussed how more evidence is needed to confirm promise of remote or decentralized trials.
• Nov. 16, 2022: Dr. Dahne received a new grant from the National Cancer Institute to test whether a proactive electronic visit would help to promote smoking cessation.
• Aug. 2021: Johanna Hidalgo was accepted to clinical psychology Ph.D. program at the University of Vermont.
• June 15, 2021: Dr. Dahne received a new grant (R41 DA053856) from the National Institute on Drug Abuse (NIDA) to develop an app-based intervention to help older adolescents quit vaping. Congratulations, Dr. Dahne!

Recent Team Publications

• *Fahey, M.C., Dahne, J., Chen, B., Smith, T.T., Wahlquist, A.E., & Carpenter, M.J. (in press). “And then I found $5”: Optimizing Recruitment Efficiency in Remote Clinical Trials. Journal of Clinical and Translational Science. doi: 10.1017/cts.2023.533. PMCID: PMC10225265. https://pubmed.ncbi.nlm.nih.gov/37250999/
• Dahne, J. & Hawk, L. W. (in press). Health Equity and Decentralized Trials. JAMA. doi: 10.1001/jama.2023.6982. PMCID: Forthcoming.
• *Fahey, M.C., Dahne, J., Wahlquist, A.E., & Carpenter, M.J. (in press). The Impact of Older Age on Smoking Cessation Outcomes After Standard Advice to Quit. Journal of Applied Gerontology. doi: 10.1177/073346482311582. PMCID: PMC10257741. https://pubmed.ncbi.nlm.nih.gov/36797652/
• Dahne, J., Player, M. S., Strange, C., Carpenter, M. J., Ford, D. W., King, K., Miller, S., Kruis, R., Hawes, E., Hidalgo, J. E., & Diaz, V. A. (2022). Proactive Electronic Visits for Smoking Cessation and COPD Screening in Primary Care: A Randomized Controlled Trial of Feasibility, Acceptability, and Efficacy. Journal of Medical Internet Research, 24(8), e38663. doi: 10.2196/38663. PMCID: PMC9472044. https://pubmed.ncbi.nlm.nih.gov/36040766/
• Dahne, J., Player, M., Carpenter, M. J., Ford, D. W., & Diaz, V. A. (2021). Evaluation of a Proactive Smoking Cessation Electronic Visit to Extend the Reach of Evidence-Based Cessation Treatment via Primary Care. Telemedicine and e-Health, 27(3), 347-354. doi: 10.1089/tmj.2020.0167. PMCID: PMC7958988. https://pubmed.ncbi.nlm.nih.gov/33085578/
• Dahne, J., Tomko, R. L., McClure, E. A., Obeid, J. S., & Carpenter, M. J. (2020). Remote Methods for Conducting Tobacco-Focused Clinical Trials. Nicotine & Tobacco Research, 22(12), 2134-2140. doi: 10.1093/ntr/ntaa105. PMCID: PMC7454765. https://pubmed.ncbi.nlm.nih.gov/32531046/
• Dahne, J., Nahhas, G. J., Wahlquist, A. E., Cummings, K. M., & Carpenter, M. J. (2020). State Tobacco Excise Taxation, Comprehensive Smoke-free Air Laws, and Tobacco Control Appropriations as Predictors of Smoking Cessation Success—Tobacco Use Supplement to the Current Population Survey, 2014-2015. Journal of Public Health Management and Practice, 26(5), E1-E4. doi: 10.1097/PHH.0000000000000865. PMCID: PMC7394937. https://pubmed.ncbi.nlm.nih.gov/32732730/
• Dahne, J., Wahlquist, A. E., Smith, T. T., & Carpenter, M. J. (2020). The Differential Impact of Nicotine Replacement Therapy Sampling on Cessation Outcomes Across Established Tobacco Disparities Groups. Preventive Medicine, 136, 106096. doi: 10.1016/j.ypmed.2020.106096. PMCID: PMC7255419. https://pubmed.ncbi.nlm.nih.gov/32320705/